We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$7.1B
AUM Growth
+$407M
Cap. Flow
-$92.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
23.68%
Holding
2,973
New
384
Increased
1,273
Reduced
905
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 23.18%
2 Financials 12.11%
3 Consumer Discretionary 12.05%
4 Healthcare 12%
5 Industrials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YMAB
1701
DELISTED
Y-mAbs Therapeutics
YMAB
$319K ﹤0.01%
9,433
+472
+5% +$15.2K
OPRX icon
1702
OptimizeRx
OPRX
$165M
$319K ﹤0.01%
5,150
INN
1703
Summit Hotel Properties
INN
$656M
$319K ﹤0.01%
34,163
-118
-0.3% -$1.17K
IDEX
1704
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$318K ﹤0.01%
+897
New +$320K
ANDE icon
1705
Andersons Inc
ANDE
$2.21B
$318K ﹤0.01%
10,431
+747
+8% +$22.5K
NTGR icon
1706
NETGEAR
NTGR
$658M
$318K ﹤0.01%
8,299
+509
+7% +$19.7K
PCG icon
1707
PG&E
PCG
$38.5B
$318K ﹤0.01%
31,248
+4,424
+16% +$47.5K
APOG icon
1708
Apogee Enterprises
APOG
$897M
$316K ﹤0.01%
7,770
+562
+8% +$21.2K
BWXT icon
1709
BWX Technologies
BWXT
$15.8B
$316K ﹤0.01%
5,438
+316
+6% +$20.3K
ANGO icon
1710
AngioDynamics
ANGO
$647M
$316K ﹤0.01%
11,640
AROC icon
1711
Archrock
AROC
$5.84B
$315K ﹤0.01%
35,405
+1,494
+4% +$13.9K
ALEC icon
1712
Alector
ALEC
$228M
$315K ﹤0.01%
15,133
+2,088
+16% +$39.4K
BMRN icon
1713
BioMarin Pharmaceuticals
BMRN
$13.6B
$315K ﹤0.01%
3,773
-8,476
-69% -$672K
MDGL icon
1714
Madrigal Pharmaceuticals
MDGL
$12.4B
$315K ﹤0.01%
3,230
+690
+27% +$81.7K
BATRK icon
1715
Atlanta Braves Holdings Series B
BATRK
$3.41B
$314K ﹤0.01%
11,318
+573
+5% +$15.7K
HNGR
1716
DELISTED
Hanger Inc.
HNGR
$314K ﹤0.01%
12,430
+700
+6% +$17.5K
INVX
1717
Innovex International
INVX
$2.15B
$314K ﹤0.01%
9,271
-1,423
-13% -$47.9K
SAH icon
1718
Sonic Automotive
SAH
$2.56B
$313K ﹤0.01%
7,005
+328
+5% +$15.9K
RUBY
1719
DELISTED
Rubius Therapeutics, Inc
RUBY
$313K ﹤0.01%
12,828
+2,620
+26% +$65.5K
SXI icon
1720
Standex International
SXI
$4B
$313K ﹤0.01%
3,295
+208
+7% +$20.2K
ZUMZ icon
1721
Zumiez
ZUMZ
$318M
$312K ﹤0.01%
6,376
+367
+6% +$16.5K
FBNC icon
1722
First Bancorp
FBNC
$2.72B
$312K ﹤0.01%
7,624
-1,216
-14% -$52.5K
SYBT icon
1723
Stock Yards Bancorp
SYBT
$2.64B
$312K ﹤0.01%
6,124
+278
+5% +$14.4K
CERE
1724
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$311K ﹤0.01%
+12,153
New +$174K
UPLD icon
1725
Upland Software
UPLD
$14.9M
$311K ﹤0.01%
756
+54
+8% +$23.7K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 Portfolio in Review

As of Q2 2021, Metropolitan Life Insurance Company (MetLife) held 2,973 positions worth $7.1B, up 6.1% from $6.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 filing shows 384 new, 1,273 increased, 905 reduced and 264 closed positions. Its largest new stake was Palantir: 112,538 shares worth $2.97M. The largest sale was Alphabet (Google) Class C, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2021 buy was Palantir: 112,538 shares worth $2.97M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $33.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $16M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $96.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $7.1B portfolio in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 384 new positions and closed 264 in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.1% quarter-over-quarter to $7.1B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.